Physician profile
Howard Eisenbrock
NPI 1447586839
$4,981.76
in general payments reported to CMS, 2019-2025
21 companies · $477 in 2025
The $477 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,547 · 2020: $599 · 2021: $375 · 2022: $481 · 2023: $411 · 2024: $1,093 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,956 · Education: $24.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,955.96 |
| Education | $24.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,472.79 | 2019-2025 | Cascadia Interbody System, Spinemask, Capri Corpectomy Cage System |
| Si-Bone, INC. | $895.23 | 2019-2024 | |
| Nevro Corp. | $389.86 | 2019-2024 | Senza |
| Medtronic, INC. | $384.46 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $117.18 | 2025 | Eterna |
| Medtronic USA, INC. | $110.22 | 2019 | |
| Providence Medical Technology, INC. | $100.79 | 2024-2025 | |
| Orthofix Medical, INC. | $96.75 | 2019-2025 | Spinal-Stim, Cervical-Stim |
| Spine Wave, INC. | $85.33 | 2019 | |
| Cerapedics INC. | $69.34 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Spinal Elements, INC. | $48.90 | 2025 | |
| Centinel Spine, LLC | $33.12 | 2019 | |
| Depuy Synthes Sales INC. | $25.48 | 2019 | |
| Globus Medical, INC. | $23.77 | 2022 | |
| Integra Lifesciences Corporation | $22.59 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $22.39 | 2019 | |
| Vertiflex, INC. | $19.78 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $17.95 | 2023 | Andexxa |
| Boston Scientific Corporation | $17.25 | 2023 | Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $15.69 | 2023 | Intracept |
| Portola Pharmaceuticals, LLC | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Eisenbrock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.